RECOMMENDATIONS Expand Access for GLP-1 Therapies Reform the Patent System: The patent system has been infected by the financialized business model of the pharmaceutical industry
Weight loss associated with semaglutide use is linked to improved reproductive measures in PMOS: a proof-of-concept analysis
Just as important, the trial results were produced under a prescription drug used as directed a research-use-only context is not the same setting, and the trial numbers cannot be assumed to transfer to it
Soliman, Karima Nasraldin, Ingy M
Oral Wegovy: A Pill Alternative For those preferring pills over injections, Oral Wegovy is a semaglutide alternative available daily
We then divided our meta-analysis into normal BMI (n = 6) 20,21,22,23,38,39 , overweight BMI (n = 14) 24,25,26,27,29,30,31,32,33,34,35,37,38,39 , and obese BMI (n = 2) 28,36 groups to further address the different HbA1c-lowering effects of GLP-1RAs